Skip to main content
. 2022 Oct 10;17(22):e202200364. doi: 10.1002/cmdc.202200364

Figure 3.

Figure 3

Monovalent (m‐dPEGx−AMB), bivalent (Bis‐dPEGx−AMB) and trivalent benzamidine (Tri‐dPEGx−AMB) inhibitors shown to scale relative to plasminogen (PDB ID: 4DUR).